• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
    All News #Library

    Enforcement Report - Week of January 29, 2025

    FDA

    Evolutionary Biologics Receives FDA Warning Letter

    FDA

    Chara Biologics Receives FDA Warning Letter

    FDA

    AB2 Bio sign agreement with Nippon for for ultra-rare disease

    GLOBENEWSWIRE

    Veru`s drug helps older obese patients on Wegovy preserve muscle

    REUTERS

    Apellis Receives Approval of Syfovre in Australia for Geographic Atrophy

    GLOBENEWSWIRE

    Supriya Lifescience posts Q3 FY25 PAT up at Rs. 46.78 Cr

    INDPHARMAPOST

    Allakos axes program, lays off 75% of staff after phase 1 flop

    FIERCE BIOTECH

    Akero`s stock doubles as midphase MASH trial hits the mark

    FIERCE BIOTECH

    Sage rejects Biogen`s $469 million takeover offer

    BIOSPACE

    Metsera targets up to $1.78 billion valuation in US IPO

    REUTERS

    Novo to cap insulin prices in settlement; joins Lilly, Sanofi

    REUTERS

    Pfizer’s BRAFTOVI Boosts Response In Mutant Colorectal Cancer

    INDPHARMAPOST

    Pankaj Patel Of Zydus Lifesciences Receives Padma Bhushan

    EXPRESSPHARMA

    PHARMEXCIL strengthens India-UAE partnership

    EXPRESSPHARMA

    Merck inaugurates the expansion of its Peenya facility in Bengaluru

    EXPRESSPHARMA

    FOPE and PharmaState Academy host session 13 of the PULSE series

    EXPRESSPHARMA

    Pharma Company May Get Time Till December For Schedule M Compliance

    ECONOMICTIMES

    China+1 Boosts India’s Share In Pharma Beyond Generics

    ECONOMICTIMES

    BP Life Sets the Standard With 99.8% Pure Fenbendazole Powder

    ACCESSWIRE

    IRLAB to Present at Redeye Investor Forum

    ACCESSWIRE

    Ascelia`s Phase 3 Data Accepted At GI Radiology Annual Meeting

    ACCESSWIRE

    Ondine Biomedical Announces HCA to invest US$4 million in Ondine

    ACCESSWIRE

    Corstasis`s Bumetanide Nasal Spray NDA Accepted By FDA

    BUSINESSWIRE

    Innate Pharma Starts Phase 1 Study For IPH4502 In Advanced Tumors

    BUSINESSWIRE

    Sarepta`s Embark Study Part 2 Shows Elevidys Benefits In DMD

    BUSINESSWIRE

    PureTech`s Vedanta Bio Phase 2 VE303 Results In Nature Medicine

    BUSINESSWIRE

    SaponiQx, Probius, & Ginkgo to revolutionize vaccine development

    INDPHARMAPOST

    Granules India Q3 FY25 PAT drops 6% to Rs 118 Cr

    PRESS RELEASE

    Merck inaugurates expansion of its Peenya facility in Bengaluru

    EXPRESSPHARMA

    Pharma may get time till Dec to comply with schedule M norms

    ECONIMICTIMES

    Trump says he may consider rejoining WHO

    REUTERS

    FDA OKs monthly maintenance dosing for Eisai/Biogen`s AD drug

    PRESS RELEASE

    Union Budget 2025-26: roadmap for India’s pharmaceutical leadership

    EXPRESSPHARMA

    CStone Partners with SteinCares to Market Sugemalimab in America

    PR NEWSWIRE

    Alivus Life Sciences delivers 12% revenue growth

    INDPHARMAPOST

    Senores Pharmaceuticals reports revenue of Rs. 288 crore in 9M FY25

    INDPHARMAPOST

    Cupid’s Female Condom Prequalified For South Africa UNFPA Tender

    INDPHARMAPOST

    Health minister seeks legal view on final schedule M draft notice

    ECONOMICTIMES

    Natera`s Ph 3 CALGB/SWOG 80702 Trial Results In Colorectal Cancer

    BUSINESSWIRE

    Boehringer merges cancer vaccine and oncolytic virus team

    ENDPTS

    Flagship forges Cambridge connection with UK research orgs

    FIERCE BIOTECH

    Trump withdraws FDA plan to ban menthol cigarettes

    REUTERS

    Ascentage Pharma’s US Shares Climb After $126 M IPO

    FIERCE BIOTECH

    Novo`s amycretin prompts 22% weight loss in early obesity trial

    ENDPTS

    Merck, Eisai combo misses survival goal in GI cancer trial

    FIERCE PHARMA

    Takeda discontinues gout med Uloric in US

    FIERCE PHARMA

    Pfizer to pay $59.7 M over kickbacks for migraine drug

    REUTERS

    US FDA drops web pages on improving clinical trial diversity

    REUTERS

    Syngene reports 18% jump in Q3 FY25 PAT at Rs. 131 Cr

    INDPHARMAPOST

    AstraZeneca Canadian investment to drive R&D growth

    EUROPEAN PHARMACEUTICAL REVIEW

    India’s Biopharma Industry Urged To Be More Ambitious

    EXPRESSPHARMA

    NMC Probes Doctors Over AbbVie-Sponsored Foreign Trips

    ECONOMICTIMES

    Adar Poonawalla: Focus On India’s Vaccine Needs Before Exports

    ECONOMICTIMES

    Lupin gets USFDA nod for generic HIV drug

    ECONOMICTIMES

    Neurocrine Bio Appoint SVP of Drug Development, Delivery & Device

    CONTRACTPHARMA

    ReiThera, SillaJen Partner On SJ-600 Clinical Trial Development

    CONTRACTPHARMA

    Veeva & Zifo Partner to Modernize QC Operations

    CONTRACTPHARMA

    Körber Names Oliver Weber CEO Software in Pharma Biz

    CONTRACTPHARMA

    Mankind Pharma net profit declines 16.20% in the Dec 2024 quarter

    BUSINESS STD

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.